Instil Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Instil Bio and other ETFs, options, and stocks.

About TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.

CEO

Bronson Crouch

CEOBronson Crouch

Employees

Employees49

Headquarters

Dallas, Texas

HeadquartersDallas, Texas

Founded

2018

Founded2018

Employees

Employees49

TIL Key Statistics

Market cap

69.72M

Market cap69.72M

Price-Earnings ratio

-0.45

Price-Earnings ratio-0.45

Dividend yield

—

Dividend yield—

Average volume

8.67K

Average volume8.67K

High today

$10.93

High today$10.93

Low today

$10.53

Low today$10.53

Open price

$10.90

Open price$10.90

Volume

6.21K

Volume6.21K

52 Week high

$14.00

52 Week high$14.00

52 Week low

$6.07

52 Week low$6.07

Instil Bio

Why Robinhood?

Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX. Show more

TIL Key Statistics

Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.